Eagle Global Advisors LLC Takes Position in Humana Inc. (HUM)
Eagle Global Advisors LLC acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the second quarter, Holdings Channel reports. The fund acquired 878 shares of the insurance provider’s stock, valued at approximately $211,000.
Several other institutional investors have also added to or reduced their stakes in the stock. Guardian Life Insurance Co. of America boosted its position in Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the period. Independent Portfolio Consultants Inc. boosted its position in Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after buying an additional 94 shares during the period. Point72 Asia Hong Kong Ltd acquired a new position in Humana during the first quarter valued at $128,000. Westbourne Investment Advisors Inc. acquired a new position in Humana during the second quarter valued at $205,000. Finally, Hengehold Capital Management LLC acquired a new position in Humana during the second quarter valued at $209,000. Institutional investors and hedge funds own 99.66% of the company’s stock.
Humana Inc. (NYSE:HUM) opened at 245.93 on Monday. Humana Inc. has a 52-week low of $163.50 and a 52-week high of $251.79. The firm’s 50 day moving average price is $236.19 and its 200 day moving average price is $220.68. The firm has a market cap of $35.54 billion, a price-to-earnings ratio of 20.23 and a beta of 0.91.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the consensus estimate of $3.08 by $0.41. The firm had revenue of $13.53 billion during the quarter, compared to the consensus estimate of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same period in the prior year, the business posted $2.30 earnings per share. Equities research analysts anticipate that Humana Inc. will post $11.40 EPS for the current fiscal year.
Several equities analysts have recently weighed in on the company. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $253.00 price objective on the stock in a report on Thursday, May 18th. BidaskClub cut Humana from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Citigroup Inc. assumed coverage on Humana in a report on Wednesday, June 28th. They set a “buy” rating and a $275.00 price objective on the stock. Credit Suisse Group reiterated an “outperform” rating and set a $260.00 price objective (up previously from $250.00) on shares of Humana in a report on Thursday. Finally, Oppenheimer Holdings, Inc. lifted their price objective on Humana from $236.00 to $255.00 and gave the company an “outperform” rating in a report on Thursday. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and twelve have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $241.65.
In related news, VP Heidi S. Margulis sold 1,500 shares of the stock in a transaction that occurred on Friday, May 26th. The stock was sold at an average price of $231.96, for a total transaction of $347,940.00. Following the completion of the sale, the vice president now directly owns 8,150 shares of the company’s stock, valued at $1,890,474. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Brian P. Leclaire sold 4,971 shares of the stock in a transaction that occurred on Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total value of $1,193,040.00. Following the sale, the senior vice president now directly owns 14,258 shares of the company’s stock, valued at $3,421,920. The disclosure for this sale can be found here. Corporate insiders own 0.80% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.